Language

English

Publication Date

2-10-2026

Journal

Journal of Controlled Release

DOI

10.1016/j.jconrel.2025.114559

PMID

41429380

PMCID

PMC12903687

PubMedCentral® Posted Date

2-14-2026

PubMedCentral® Full Text Version

Post-print

Abstract

Long-acting antiretroviral therapy (LA-ART) holds promise for improving adherence and viral suppression in human immunodeficiency virus (HIV) prevention and treatment, respectively. These LA-ART encompass different delivery modalities such as intravaginal rings, subcutaneous implants, and intramuscular or subcutaneous injectables. However, subcutaneous implants, especially those containing tenofovir alafenamide (TAF), can trigger local inflammation. In this study, we incorporated MCC950, a selective NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inhibitor, into a subcutaneous nanofluidic implant co-delivering TAF and bictegravir (BIC). In a rodent model, MCC950 reduced local inflammation, fibrotic capsule formation, and inflammatory cell infiltration without affecting the antiviral activity of TAF or BIC. Sustained plasma levels of both drugs were maintained for up to 45 days, and imaging mass cytometry and histological analyses confirmed localized immunomodulation. These findings establish inflammasome inhibition as a viable strategy to improve the safety and tolerability of subcutaneous LA-ART and lay the groundwork for future immunomodulatory-enhanced drug delivery systems.

Keywords

Animals, Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein, HIV Infections, Anti-HIV Agents, Female, Tenofovir, Foreign-Body Reaction, Adenine, Delayed-Action Preparations, Mice, Humans, Drug Implants, Furans, Heterocyclic Compounds, 4 or More Rings, Alanine, Indenes, Sulfonamides, long-acting drug delivery, subcutaneous implant, foreign body response, NLRP3 inflammasome inhibition, antiretroviral therapy (ART)

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.